1. | EXECUTIVE SUMMARY |
1.1. | Global Healthcare Spending is Rising |
1.2. | Factors Encouraging the Rise of Digital Health |
1.3. | Remote Patient Monitoring is Changing the Face of Healthcare |
1.4. | The Benefits of Remote Patient Monitoring for Payers |
1.5. | Remote Patient Monitoring: Measurements and Applications |
1.6. | Market Outlook: Medical Devices |
1.7. | RPM in the Hospital |
1.8. | RPM in the Hospital: Conclusions and Outlook |
1.9. | RPM for Cardiovascular Diseases |
1.10. | RPM for Cardiovascular Diseases: Conclusions and Outlook |
1.11. | Diabetes management process |
1.12. | RPM for Diabetes: Conclusions and Outlook |
1.13. | Respiratory diseases are leading causes of death |
1.14. | RPM for Respiratory Diseases: Conclusions and Outlook |
1.15. | Remote Monitoring Benefits Carers of the Young and the Old |
1.16. | Monitoring for the Young and Elderly: Conclusions and Outlook |
1.17. | Medical Adherence is a Billion-Dollar Opportunity |
1.18. | Medical Adherence: Conclusions and Outlook |
1.19. | Wearables for the insurance sector: people and pets |
1.20. | Wellness: Conclusions and Outlook |
1.21. | The Outlook for Remote Patient Monitoring |
2. | INTRODUCTION |
2.1. | Scope of Report |
2.2. | Changing Demographics Require Healthcare Reforms |
2.3. | Global Healthcare Spending is Rising |
2.4. | Factors Encouraging the Rise of Digital Health |
2.5. | Consumer-Driven, Patient Centered Healthcare |
2.6. | Telehealth and Telemedicine are Poised for Take-Off |
2.7. | Remote Patient Monitoring is Changing the Face of Healthcare |
2.8. | Driving the Uptake of Telemedicine |
2.9. | Changes to Reimbursement of Telehealth |
2.10. | Reimbursement of Remote Patient Monitoring |
2.11. | The Benefits of Remote Patient Monitoring for Payers |
2.12. | Remote Patient Monitoring: Measurements and Applications |
2.13. | Components of a Remote Monitoring System |
2.14. | Remote Patient Monitoring in Hospitals and the Home |
2.15. | RPM: From Connected to Wearable |
3. | TECHNOLOGIES |
3.1. | The Role of Wearables |
3.1.1. | Introduction |
3.1.2. | Wearable Sensors in Three Waves |
3.1.3. | The First Wave: "The Originals" |
3.1.4. | The Second Wave: "Made-Wearable" Sensors |
3.1.5. | The Third Wave: "Made-for-Wearable" Sensors |
3.1.6. | Wearables 2016-2018: Commoditisation, Shakeout, Maturity |
3.1.7. | Wearables as a Sum of its Parts |
3.1.8. | Wearables 2018-Onwards: Core Value Shines Through |
3.1.9. | Wearables - technology hype and drivers |
3.1.10. | Integration into clothing |
3.1.11. | Examples E-Textiles in RPM |
3.1.12. | Skin Patches - A True Wearable |
3.1.13. | Skin patches competing with established products |
3.1.14. | New market creation around skin patches |
3.1.15. | Applications, market sizes and outlook |
3.1.16. | Market Outlook: Medical Devices |
3.2. | Wearable Sensor Technologies |
3.2.1. | Sensors in Wearable Medical Devices |
3.2.2. | Common Wearable Sensors Deployed Today |
3.2.3. | Sensors on the Body: What do we want to Measure? |
3.2.4. | Appropriate Data for the Desired Outcome |
3.2.5. | Example: Effort and Reward in Heart Monitoring |
3.2.6. | Example: Useful Data at Different Levels of Inference |
3.2.7. | Sensor Fusion is Essential and Expected |
3.2.8. | Sensor Fusion is Essential and Expected |
3.2.9. | Different Product Types from the Same Sensors |
3.2.10. | Photoplethysmography (PPG) |
3.2.11. | Transmission-mode PPG |
3.2.12. | Reflectance-mode PPG |
3.2.13. | Measuring Electrical Properties of the Body |
3.2.14. | Measuring Biopotential |
3.2.15. | Biopotential: Signal Frequency and Amplitude |
3.2.16. | ECG |
3.2.17. | EEG |
3.2.18. | EMG |
3.2.19. | Circuit Construction for Measuring Biopotential |
3.2.20. | Properties of Wearable Electrodes |
3.2.21. | Dry electrodes: Challenges and Solutions |
3.2.22. | Optical Chemical Sensors |
3.2.23. | Selectivity and Signal transduction in Chemical Sensors |
3.2.24. | Stretch / Pressure Sensors |
3.2.25. | Stretch / Pressure Sensors - Respiration Rate |
3.2.26. | Types of Temperature Sensor |
3.2.27. | Approaches and Standards for Medical Temperature Sensors |
3.2.28. | Core Body Temperature |
4. | APPLICATIONS |
4.1. | Monitoring in the Hospital |
4.1.1. | Remote Patient Monitoring in the Hospital Setting |
4.1.2. | Medtronic - Vital Sync |
4.1.3. | EarlySense |
4.1.4. | VitalConnect |
4.1.5. | Sensium (Surgical Company Group) |
4.1.6. | Capsule Technologies |
4.1.7. | LifeSignals |
4.1.8. | MC10 |
4.1.9. | Inpatient monitoring: The case for removing the wires |
4.1.10. | Hospital-acquired pressure ulcers |
4.1.11. | Medicus Tek: Sensable Care |
4.1.12. | Sensing Tex |
4.1.13. | Leaf Healthcare |
4.1.14. | Conclusions and Outlook |
4.2. | Cardiovascular |
4.2.1. | RPM improves cardiovascular disease outcomes |
4.2.2. | Heart monitoring |
4.2.3. | Select History of Wearable Medical Devices - Cardiac |
4.2.4. | Wearable, ambulatory cardiac monitoring: Comparison of over 30 players |
4.2.5. | Progress towards ambulatory cardiac monitoring |
4.2.6. | Differentiation between ambulatory cardiac monitors |
4.2.7. | iRhythm: ZIO |
4.2.8. | VivaLNK |
4.2.9. | Wearable vs implantable monitoring |
4.2.10. | Pacemakers and other cardiac rhythm implants |
4.2.11. | Medtronic - CareLink |
4.2.12. | Boston Scientific - Latitude |
4.2.13. | Comparison: Apparel |
4.2.14. | ChronoLife |
4.2.15. | @-Health - CardioNexion® |
4.2.16. | Comparison: Consumer Portable Devices |
4.2.17. | AliveCor |
4.2.18. | Comparison: Smartwatch optical HRM |
4.2.19. | Valencell |
4.2.20. | Cosinuss |
4.2.21. | toSense |
4.2.22. | Select History of Wearable Medical Devices - Blood Pressure |
4.2.23. | Omron |
4.2.24. | Blood pressure from other heart biometrics |
4.2.25. | TLT & ViCardio |
4.2.26. | Conclusions and Outlook |
4.3. | Diabetes |
4.3.1. | Diabetes on the rise |
4.3.2. | Managing side effects accounts for 90% of the total cost of diabetes |
4.3.3. | Diabetes management process |
4.3.4. | Diabetes management device roadmap: Glucose sensors |
4.3.5. | Connected and Smartphone-based Glucometers |
4.3.6. | The case for CGM |
4.3.7. | Skin patches are the form factor of choice |
4.3.8. | CGM: Overview of key players |
4.3.9. | Implantable glucose sensors: Introduction |
4.3.10. | Key Players in Implantable Glucose Monitoring |
4.3.11. | Focus shifts from test strips to CGM |
4.3.12. | Strategy comparison amongst the largest players |
4.3.13. | CGM options are expanding |
4.3.14. | Diabetes management device roadmap: Insulin delivery |
4.3.15. | Diabetes Monitoring: Closing the feedback loop? |
4.3.16. | Diabetes Monitoring: Current commercial situation |
4.3.17. | Diabetes is an Early Adopter of Digital Healthcare Initiatives |
4.3.18. | Diabetes apps |
4.3.19. | Smarter insulin delivery informing decisions |
4.3.20. | Smart Pen Platform Preventing Missed Doses |
4.3.21. | Smart insulin delivery device manufacturers |
4.3.22. | Monitoring Adherence to Therapy |
4.3.23. | Connected Devices for DFU Prevention |
4.3.24. | Amazon Tackles Diabetes Care |
4.3.25. | Conclusions and Outlook |
4.4. | Respiratory |
4.4.1. | Respiratory diseases are leading causes of death |
4.4.2. | COPD and Asthma |
4.4.3. | Smart Inhalers |
4.4.4. | Smart Inhalers: Companies |
4.4.5. | Propeller Health |
4.4.6. | Propeller - Novartis in Asthma Care |
4.4.7. | Real-time air quality data - BreezoMeter |
4.4.8. | Smart Spirometer |
4.4.9. | Microphones and AI for respiratory diagnostics |
4.4.10. | Respiri |
4.4.11. | Spire Health |
4.4.12. | Smoking Cessation: Carrot / Pivot |
4.4.13. | RPM in Tuberculosis Treatment |
4.4.14. | Conclusions and Outlook |
4.5. | Monitoring of Infants and the Elderly |
4.5.1. | Remote Monitoring Benefits Carers of the Young and the Old |
4.5.2. | Baby Monitoring - Addressing SIDS |
4.5.3. | Smart Socks |
4.5.4. | Owlet |
4.5.5. | Smart Baby Cameras |
4.5.6. | Temperature and Moisture Sensors |
4.5.7. | Diaper Monitoring |
4.5.8. | Blue Spark |
4.5.9. | VivaLNK |
4.5.10. | Rest Devices |
4.5.11. | Elder Care - Detecting and Preventing Falls |
4.5.12. | Abeye |
4.5.13. | CarePredict |
4.5.14. | E-Vone |
4.5.15. | Philips |
4.5.16. | Welt |
4.5.17. | Xandar Kardian |
4.5.18. | Conclusions and Outlook |
4.6. | Medical Adherence |
4.6.1. | Medical Adherence is a Billion-Dollar Opportunity |
4.6.2. | Digital Pill - Proteus Digital Health |
4.6.3. | As Directed Plus |
4.6.4. | Cardinal Health |
4.6.5. | Corbit |
4.6.6. | Stanley Black & Decker and Pillo Health |
4.6.7. | Smart Pill Boxes |
4.6.8. | Connected Pill Bottle Caps |
4.6.9. | Conclusions and Outlook |
4.7. | Wellness |
4.7.1. | Fitness and Wellness |
4.7.2. | Corporate Wellness |
4.7.3. | Wearables for the insurance sector: people and pets |
4.7.4. | UnitedHealthcare Motion: US |
4.7.5. | Momentum Multiple: South Africa |
4.7.6. | Vitality: UK |
4.7.7. | Vitality and Apple Watch |
4.7.8. | Fitbit |
4.7.9. | Conclusions and Outlook |
5. | CONCLUSIONS |
5.1. | Is Remote Patient Monitoring Really Helpful? |
5.2. | The Outlook for Remote Patient Monitoring |
6. | APPENDIX |
6.1. | List of Company Profiles |
6.2. | List of Abbreviations |